Compliance Notes - BioPharm International

ADVERTISEMENT

Compliance Notes

How to Respond to Consent Decrees

May 1, 2012

How to handle and respond to a consent decree.

Preparing for an FDA Inspection in a Global Pharmaceutical Environment

April 1, 2012

FDA has created a dedicated cadre of foreign drug investigators and established permanent offices worldwide.

Putting Risk-Based Decision-Making Where It Belongs

March 1, 2012

Focusing on how risk affects the entire organization can improve the business bottom line.

Auditing by the Numbers

January 1, 2012

Contract organizations must have highly organized teams and plans to accommodate today's audits.

Developing and Sustaining a Quality Culture

November 1, 2011

In a culture of quality, it is important that employees adopt this mindset, not because they have to, but because they understand the importance.

Following Our Own Instructions

September 1, 2011

Why SOPs are rarely followed, often cited, and in great need of follow-through.

Impact of cGMP on Supply Chain

July 1, 2011

Incorporating regulatory requirements into the product life cycle is crucial.

Quality by Design: The Case for Change (Part II)

May 1, 2011

A rigorous cost-benefit assessment can help to chart a cost-effective path forward.

Quality by Design: The Case for Change

March 1, 2011

Executive management leadership is essential in the effective implementation of QbD.

ADVERTISEMENT

ADVERTISEMENT

Click here